About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Sentinel Lymph Node Detection in Prostate Surgery by Laparoscopy

NCT01296217·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Centre René Gauducheau

Age

18–any

Sex

MALE

Healthy volunteers

Not accepted

You may be eligible if

Age\> 18 years
Diagnosis of invasive cancer of the prostate (T1 or T2 or T3)
PSA ≥ 4,
Gleason ≥ 6
No treatment prior to surgery
Indication of lymphadenectomy by coeliscopique
ECOG or Karnofsky index 2
Patient information and signed informed consent

You may not be if

neoadjuvant hormone therapy
Interventions prior pelvic
Patients who received anterior resection of part of prostate
Patient or denied having an altered mental status
Any contre indication to laparoscopy

The record

StatusCompleted

PhaseNo phase

Taking part24

Started—

UpdatedMar 4, 2011

Conditions

Prostatic Neoplasms

Where1

Centre René Gauducheau
Nantes, France

Clareo Health | Sentinel Lymph Node Detection in Prostate Surgery by Laparoscopy